AU2005269724B2 - Growth hormone releasing hormone enhances the immune response induced by vaccination - Google Patents

Growth hormone releasing hormone enhances the immune response induced by vaccination Download PDF

Info

Publication number
AU2005269724B2
AU2005269724B2 AU2005269724A AU2005269724A AU2005269724B2 AU 2005269724 B2 AU2005269724 B2 AU 2005269724B2 AU 2005269724 A AU2005269724 A AU 2005269724A AU 2005269724 A AU2005269724 A AU 2005269724A AU 2005269724 B2 AU2005269724 B2 AU 2005269724B2
Authority
AU
Australia
Prior art keywords
ghrh
subject
nucleic acid
tissue
expression construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2005269724A
Other languages
English (en)
Other versions
AU2005269724A1 (en
Inventor
Patrica A. Brown
William C. Davis
Ruxandra Draghia-Akli
Amir S. Khan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advisys Inc
Original Assignee
Advisys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advisys Inc filed Critical Advisys Inc
Publication of AU2005269724A1 publication Critical patent/AU2005269724A1/en
Application granted granted Critical
Publication of AU2005269724B2 publication Critical patent/AU2005269724B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2005269724A 2004-07-23 2005-07-21 Growth hormone releasing hormone enhances the immune response induced by vaccination Expired AU2005269724B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59073904P 2004-07-23 2004-07-23
US60/590,739 2004-07-23
PCT/US2005/025747 WO2006014737A2 (en) 2004-07-23 2005-07-21 Growth hormone releasing hormone enhances the immune response induced by vaccination

Publications (2)

Publication Number Publication Date
AU2005269724A1 AU2005269724A1 (en) 2006-02-09
AU2005269724B2 true AU2005269724B2 (en) 2011-03-10

Family

ID=35717476

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005269724A Expired AU2005269724B2 (en) 2004-07-23 2005-07-21 Growth hormone releasing hormone enhances the immune response induced by vaccination

Country Status (10)

Country Link
US (1) US20060025368A1 (enExample)
EP (1) EP1809336B1 (enExample)
JP (1) JP2008507537A (enExample)
CN (1) CN101027081A (enExample)
AT (1) ATE413890T1 (enExample)
AU (1) AU2005269724B2 (enExample)
DE (1) DE602005011041D1 (enExample)
MX (1) MX2007000893A (enExample)
NZ (1) NZ553274A (enExample)
WO (1) WO2006014737A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846720B2 (en) * 2005-01-26 2010-12-07 Vgx Pharmaceuticals, Inc. Optimized high yield synthetic plasmids
JP2011504111A (ja) * 2007-05-21 2011-02-03 サイト パルス サイエンシズ、インコーポレイテッド ポリヌクレオチドワクチンを哺乳類の皮膚に送達するための方法及び装置
WO2010044919A2 (en) * 2008-05-28 2010-04-22 Vgx Pharmaceuticals, Inc. Smallpox dna vaccine and the antigens therein that elicit an immune response
CN108707589B (zh) * 2018-06-07 2021-11-26 西南民族大学 一种牛病毒性腹泻病毒SMU-Z6/1a/SC/2016分离株及其应用
CN116328742B (zh) * 2023-04-27 2024-08-30 大连理工大学 一种核壳型磁性分子印迹聚合物材料、制备方法及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049700A2 (en) * 2001-12-11 2003-06-19 Advisys, Inc. Growth hormone releasing hormone suplementation for treating chronically ill subjects
WO2003099341A1 (en) * 2002-05-28 2003-12-04 Advisys, Inc. Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224316A (en) * 1979-03-30 1980-09-23 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223020A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223019A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228156A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223021A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4226857A (en) * 1979-03-30 1980-10-07 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228158A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4410512A (en) * 1981-12-28 1983-10-18 Beckman Instruments, Inc. Combinations having synergistic pituitary growth hormone releasing activity
US5134120A (en) * 1984-08-03 1992-07-28 Cornell Research Foundation, Inc. Use of growth hormone to enhance porcine weight gain
US5036045A (en) * 1985-09-12 1991-07-30 The University Of Virginia Alumni Patents Foundation Method for increasing growth hormone secretion
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US4833166A (en) * 1987-05-01 1989-05-23 Grosvenor Clark E Growth hormone releasing hormone complementary peptides
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
USRE33699E (en) * 1987-07-09 1991-09-24 International Minerals & Chemical Corp. Growth hormone-releasing factor analogs
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5023322A (en) * 1988-08-31 1991-06-11 Mta Kutatas-Es Szervezetelemzo Intezete Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5134210A (en) * 1989-07-27 1992-07-28 Edwards Bill R Acrylic resin composition
US5137872A (en) * 1989-09-18 1992-08-11 Pitman-Moore, Inc. Growth hormone-releasing factor analogs
JPH06500311A (ja) * 1990-06-29 1994-01-13 エフ・ホフマン―ラ　ロシュ　アーゲー ヒスチジン置換されたヒト成長ホルモン放出因子類縁体
US5486505A (en) * 1990-07-24 1996-01-23 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
AU662731B2 (en) * 1991-04-09 1995-09-14 F. Hoffmann-La Roche Ag Growth hormone releasing factor analogs
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5439440A (en) * 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5792747A (en) * 1995-01-24 1998-08-11 The Administrators Of The Tulane Educational Fund Highly potent agonists of growth hormone releasing hormone
WO1996032126A1 (en) * 1995-04-14 1996-10-17 The Administrators Of The Tulane Educational Fund Analogs of growth hormone-releasing factor
PT994721E (pt) * 1997-05-01 2007-03-30 Protechtion Unltd Inc Factor de crescimento do tecido nervoso como adjuvante de vacina
BR0001606A (pt) * 1999-04-12 2001-04-24 Pfizer Prod Inc Composições de hormÈnio de crescimento e de hormÈnio de liberação de hormÈnio de crescimento
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
WO2003047602A1 (en) * 2001-12-07 2003-06-12 Intercell Ag Immunostimulatory oligodeoxynucleotides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049700A2 (en) * 2001-12-11 2003-06-19 Advisys, Inc. Growth hormone releasing hormone suplementation for treating chronically ill subjects
WO2003099341A1 (en) * 2002-05-28 2003-12-04 Advisys, Inc. Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DRAGHIA-AKLI R et al. Mol. Ther. 2002. 6(6): 830-836 *
KHORRAM O et al. Journal of Clinical Endocrinology and Metabolism. 1997. 82(11): 3592-3593 *
KHORRAM O et al. Journal of Clinical Endocrinology and Metabolism. 2001. 86(7): 3157-3161 *
LEROITH D et al. Endocrinology. 1996. 137(3): 1071-1079 *

Also Published As

Publication number Publication date
US20060025368A1 (en) 2006-02-02
AU2005269724A1 (en) 2006-02-09
WO2006014737A2 (en) 2006-02-09
NZ553274A (en) 2010-02-26
EP1809336B1 (en) 2008-11-12
JP2008507537A (ja) 2008-03-13
ATE413890T1 (de) 2008-11-15
CN101027081A (zh) 2007-08-29
DE602005011041D1 (de) 2008-12-24
EP1809336A2 (en) 2007-07-25
WO2006014737A3 (en) 2006-05-11
MX2007000893A (es) 2007-04-18

Similar Documents

Publication Publication Date Title
US20090292107A1 (en) Composition and method to alter lean body mass and bone properties in a subject
EP1465654B1 (en) Plasmid mediated supplementation for treating chronically ill subjects
AU2002348417A1 (en) A composition and method to alter lean body mass and bone properties in a subject
US20040192593A1 (en) Protease resistant ti-growth hormone releasing hormone
AU2005269724B2 (en) Growth hormone releasing hormone enhances the immune response induced by vaccination
CA2592891C (en) Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
JP2008507537A5 (enExample)
US7517863B2 (en) Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide
US8058253B2 (en) Growth hormone releasing hormone treatment to decrease cholesterol levels
CA2563312C (en) Plasmid mediated ghrh supplementation for renal failures
US20090005333A1 (en) Reducing culling in herd animals growth hormone releasing hormone (ghrh)
US20080221034A1 (en) Canine specific growth hormone releasing hormone
MC et al. GHRH ZUR VERWENDUNG BEI DER BEHANDLUNG VON CHRONISCHER NIERENINSUFFIZIENZ GHRH POUR LE TRAITEMENT DES INSUFFISANCES RENALES CHRONIQUES

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired